• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

功能性运动障碍临床研究的纳入标准一致性:一项系统评价。

Consistency of inclusion criteria for functional movement disorder clinical research studies: A systematic review.

作者信息

Kirkwood Brian, Mark Victor W

机构信息

Department of Physical Medicine and Rehabilitation, University of Alabama at Birmingham, Birmingham, AL, USA.

Department of Neurology, University of Alabama at Birmingham, Birmingham, AL, USA.

出版信息

NeuroRehabilitation. 2022;50(2):169-178. doi: 10.3233/NRE-228002.

DOI:10.3233/NRE-228002
PMID:35213329
Abstract

BACKGROUND

Functional movement disorders (FMDs) are a common cause of disability. With an increasing research interest in FMD, including the emergence of intervention trials, it is crucial that research methodology be examined, and standardized protocols be developed.

OBJECTIVE

To characterize the current inclusion criteria used to select patients for FMD research studies and review the consistency and appropriateness of these criteria.

METHODS

We identified studies of potential biomarkers for FMD that were published over the last two decades and performed a qualitative analysis on the finally included studies.

RESULTS

We identified 79 articles and found inconsistent inclusion criteria. The Fahn-Williams and DSM-IV criteria were the most commonly applied, but neither accounted for the majority (Fahn-Williams 46%, DSM-IV 32% of the total). The selection of the inclusion criteria depended in part on the phenotype of FMD under investigation. We also identified inclusion methodologies that were not appropriate, such as the inclusion of low-certainty diagnoses and diagnosing by excluding specific biomarkers rather than including patients based on clinical characteristics that commonly are thought to suggest FMD.

CONCLUSIONS

Significant variability exists with the inclusion criteria for FMD research studies. This variability could limit reproducibility and the appropriate aggregation of data for meta-analysis. Advancing FMD rehabilitation research will need standardized inclusion criteria. We make some suggestions.

摘要

背景

功能性运动障碍(FMDs)是导致残疾的常见原因。随着对FMD研究兴趣的增加,包括干预试验的出现,审视研究方法并制定标准化方案至关重要。

目的

描述目前用于选择FMD研究患者的纳入标准,并审查这些标准的一致性和适当性。

方法

我们检索了过去二十年发表的关于FMD潜在生物标志物的研究,并对最终纳入的研究进行了定性分析。

结果

我们识别出79篇文章,发现纳入标准不一致。法恩-威廉姆斯标准和《精神疾病诊断与统计手册》第四版(DSM-IV)标准应用最为广泛,但两者均未占多数(法恩-威廉姆斯标准占总数的46%,DSM-IV标准占32%)。纳入标准的选择部分取决于所研究的FMD表型。我们还发现了不合适的纳入方法,例如纳入低确定性诊断以及通过排除特定生物标志物而非基于通常被认为提示FMD的临床特征纳入患者来进行诊断。

结论

FMD研究的纳入标准存在显著差异。这种差异可能会限制可重复性以及荟萃分析数据的适当汇总。推进FMD康复研究需要标准化的纳入标准。我们提出了一些建议。

相似文献

1
Consistency of inclusion criteria for functional movement disorder clinical research studies: A systematic review.功能性运动障碍临床研究的纳入标准一致性:一项系统评价。
NeuroRehabilitation. 2022;50(2):169-178. doi: 10.3233/NRE-228002.
2
Home treatment for mental health problems: a systematic review.心理健康问题的居家治疗:一项系统综述
Health Technol Assess. 2001;5(15):1-139. doi: 10.3310/hta5150.
3
Systemic treatments for metastatic cutaneous melanoma.转移性皮肤黑色素瘤的全身治疗
Cochrane Database Syst Rev. 2018 Feb 6;2(2):CD011123. doi: 10.1002/14651858.CD011123.pub2.
4
Cost-effectiveness of using prognostic information to select women with breast cancer for adjuvant systemic therapy.利用预后信息为乳腺癌患者选择辅助性全身治疗的成本效益
Health Technol Assess. 2006 Sep;10(34):iii-iv, ix-xi, 1-204. doi: 10.3310/hta10340.
5
Oxycodone for cancer-related pain.羟考酮治疗癌性疼痛。
Cochrane Database Syst Rev. 2022 Jun 9;6(6):CD003870. doi: 10.1002/14651858.CD003870.pub7.
6
Interventions for promoting habitual exercise in people living with and beyond cancer.促进癌症患者及康复者进行习惯性锻炼的干预措施。
Cochrane Database Syst Rev. 2018 Sep 19;9(9):CD010192. doi: 10.1002/14651858.CD010192.pub3.
7
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.在基层医疗机构或医院门诊环境中,如果患者出现以下症状和体征,可判断其是否患有 COVID-19。
Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3.
8
Shared decision-making interventions for people with mental health conditions.心理健康问题患者的共同决策干预措施。
Cochrane Database Syst Rev. 2022 Nov 11;11(11):CD007297. doi: 10.1002/14651858.CD007297.pub3.
9
Music interventions for improving psychological and physical outcomes in people with cancer.音乐干预对改善癌症患者心理和生理结局的影响。
Cochrane Database Syst Rev. 2021 Oct 12;10(10):CD006911. doi: 10.1002/14651858.CD006911.pub4.
10
Nivolumab for adults with Hodgkin's lymphoma (a rapid review using the software RobotReviewer).纳武单抗用于成人霍奇金淋巴瘤(使用RobotReviewer软件进行的快速综述)
Cochrane Database Syst Rev. 2018 Jul 12;7(7):CD012556. doi: 10.1002/14651858.CD012556.pub2.

引用本文的文献

1
Biomarkers and Rehabilitation for Functional Neurological Disorder.功能性神经障碍的生物标志物与康复
J Pers Med. 2024 Sep 7;14(9):948. doi: 10.3390/jpm14090948.
2
Functional neurological symptom disorder in a patient with hemibody weakness: A case report.一名半身无力患者的功能性神经症状障碍:病例报告。
SAGE Open Med Case Rep. 2024 Jul 26;12:2050313X241267073. doi: 10.1177/2050313X241267073. eCollection 2024.
3
Optimizing outcomes when treating functional neurological disorder in acute care settings: case reports depicting the value of diagnostic precision and timely and appropriate psychological interventions using an interdisciplinary framework.
优化急性护理环境中功能性神经障碍的治疗效果:病例报告展示了使用跨学科框架进行精确诊断以及及时、适当的心理干预的价值。
Front Psychiatry. 2024 Jun 6;15:1288828. doi: 10.3389/fpsyt.2024.1288828. eCollection 2024.